Specializes in gene therapy, offering process development, viral vector production, and integrated solutions for clinical applications in the biopharmaceutical industry.
Baltimore
Baltimore City
Maryland
Notice Date
August 20, 2025
October 18, 2025
Unavailable
31 Manufacturing
More WARN Notices from